# A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects

> **NCT01284036** · PHASE1 · COMPLETED · sponsor: **Ablynx, a Sanofi company** · enrollment: 63 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-05230905

## Key facts

- **NCT ID:** NCT01284036
- **Lead sponsor:** Ablynx, a Sanofi company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284036, "A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01284036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*